A survey of the scientific and patent literature on single-nucleotide variants reveals the dominance of research centers in the United States and the prolific patenting of SNP technology by a select group of biotechnology companies.
- Roger Coronini
- Marie-Angèle de Looze
- Shyama V. Ramani